A randomised controlled trial of NMDA antagonist, memantine, for the treatment of borderline personality disorder

  • Kulkarni, Jayashri (Primary Chief Investigator (PCI))
  • Plebanski, Magdalena (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/1731/12/19

Funding

  • National Health & Medical Research Council (NHMRC): AUD993,067.00